Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Estimation of potential social support requirement for tuberculosis patients in India.
Chatterjee, S; Stallworthy, G; Das, P; VASSALL, A;
2024
Health policy and planning, (2024).39 8 10.1093/heapol/czae065.
Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study.
Muwanga, VM; Mendelsohn, SC; Leukes, V; Stanley, K; Mbandi, SK; Erasmus, M; Flinn, M; Fisher, T-L; Raphela, R; Bilek, N; Malherbe, ST; Tromp, G; Van Der Spuy, G; Walzl, G; Chegou, NN; Scriba, TJ;
2024
European Respiratory Journal, (2024).64 2 10.1183/13993003.00153-2024.
An open-access database to navigate Mycobacterium tuberculosis genetic diversity.
Wall, R; PHELAN, J;
2024
(2024).
Need for high-resolution observational cohort studies to understand the natural history of tuberculosis.
LARSSON, L; CALDERWOOD, CJ; Gupta, RK; Khosa, C; KRANZER, K;
2024
The Lancet. Microbe, (2024).5 10 10.1016/s2666-5247(24)00140-x.
The inclusion of children and adolescents in tuberculosis diagnostic development and evaluation-a consensus statement.
Bijker, EM; Horn, L; LaCourse, S; MacLean, EL; Marais, BJ; Nicol, MP; Olbrich, L; Seddon, JA; SUTHERLAND, JS; Song, R; Zar, HJ; Jaganath, D; Child TB Diagnostics Consensus Group,;
2024
The Lancet. Infectious diseases, (2024).24 11 10.1016/s1473-3099(24)00339-6.
Vitamin B12 uptake and regulation of resuscitation from dormancy in Mycobacterium tuberculosis.
KIPKORIR, T;
2024
(2024).
Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery.
Daniel, C; WILLCOCKS, S; Bhakta, S;
2024
Methods in molecular biology (Clifton, N.J.), (2024).2833, 10.1007/978-1-0716-3981-8_3.
Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence.
Matteelli, A; Churchyard, G; Cirillo, D; Den Boon, S; Falzon, D; Hamada, Y; HOUBEN, RM G J; Kanchar, A; Kritski, A; Kumar, B; Miller, C; Menzies, D; Masini, T;
2024
PLOS Global Public Health, (2024).4 7 10.1371/journal.pgph.0003306.
Implications of subclinical tuberculosis for vaccine trial design and global effect.
Churchyard, GJ; HOUBEN, RM G J; FIELDING, K; Fiore-Gartland, AL; Esmail, H; GRANT, AD; Rangaka, MX; Behr, M; Garcia-Basteiro, AL; Wong, EB; Hatherill, M; Mave, V; Dagnew, AF; Schmidt, AC; Hanekom, WA; Cobelens, F; WHITE, RG;
2024
The Lancet. Microbe, (2024).5 10 10.1016/S2666-5247(24)00127-7.
Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China.
SWEENEY, S; FIELDING, K; Liu, X; THOMPSON, JA; Dong, H; Jiang, S; Zhao, Y; Huan, S; VASSALL, A;
2024
IJTLD open, (2024).1 7 10.5588/ijtldopen.23.0451.